Tiger Brokers

BUZZ-ASX-listed Mesoblast jumps on key drug's quarterly sales surge

Reuters
Oct 07
BUZZ-ASX-listed Mesoblast jumps on key drug's quarterly sales surge

** ASX-listed Mesoblast MSB.AX pares early surge to trade 8.1% higher at A$2.8 by midday in Sydney, still among the top ASX200 .AXJO gainers while the benchmark edges lower

** Inflammatory diseases' medicine maker reports Ryoncil drug's rev increasing 66% QoQ

** Ryoncil is used to treat steroid-refractory acute graft versus host disease, a condition that can occur after blood cell transplant, in paediatric patients

** Over 8.3 million shares traded, 1.5x of the 30-day avg

** Stock down 10.3% including current session on a YTD basis

(Reporting by Kumar Tanishk in Bengaluru)

((Tanishk.Kumar@thomsonreuters.com; X: @thatstanishk http://www.x.com/thatstanishk;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10